Showing results (801-810 of 903) with videos related to

Sort By:
Pageof 91
Clinical and Translational Radiation Oncology|January 14, 2026
Impact of tumour proximity to organs-at-risk in adaptive MR-guided SBRT for central lung tumours and metastasesSina Mansoorian, Ala Sami Ismail Salameh, Laura Hamm, et al.
Plos One|February 15, 2019
3D grating-based X-ray phase-contrast computed tomography for high-resolution quantitative assessment of cartilage: An experimental feasibility study with 3T MRI, 7T MRI and biomechanical correlationJulia Herzen, Dimitrios C Karampinos, Peter Foehr, et al.
Journal of Hypertension|March 19, 2024
Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medicationJanis M Nolde, Emily Atkins, Simone Marschner, et al.
Cancers|October 3, 2020
Advanced Fusion Imaging and Contrast-Enhanced Imaging (CT/MRI-CEUS) in OncologyVincent Schwarze, Johannes Rübenthaler, Constantin Marschner, et al.
Frontiers in Dental Medicine|March 23, 2026
Structured reporting of dental panoramic images in a hospital-based radiology setting: a comparative studyMoritz Ludwig Schnitzer, Gloria Biechele, Emilia Schober, et al.
Physics in Medicine and Biology|June 26, 2025
Deep learning-based contour propagation in magnetic resonance imaging-guided radiotherapy of lung cancer patientsChengtao Wei, Chukwuka Eze, Rabea Klaar, et al.
Nutrients|March 28, 2024
Randomised Controlled Trial of a Customised Text Messaging and Activity Monitor Program for Lifestyle Improvement after Gestational DiabetesNgai Wah Cheung, David Simmons, Simone Marschner, et al.
Journal of Medicinal Chemistry|July 31, 2024
Structural Optimization of Oxaprozin for Selective Inverse Nurr1 AgonismSabine Willems, Romy Busch, Felix Nawa, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 30, 2026
Stereotactic heart ablative radiotherapy (SHARP): a prospective multicentric phase II trialAurélie Gaasch, Sebastian N Marschner, Philipp Hoegen-Saßmannshausen, et al.
Cancer Research|October 19, 2007
A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent Fc-dependent effector activityDavid A Rider, Carin E G Havenith, Ruby de Ridder, et al.
Pageof 91